Tamar NIV LTD, a developer of neurosurgical robotic technology solutions, has developed and deployed a protective patient hood for use in hospitals. Known as the NIV Greenhouse™, the hood prevents the spread of COVID-19 and protects medical teams when applying non-invasive ventilation therapy for COVID-19 patients. It enables the use of non-invasive ventilation such as CPAP and BiPAP devices in COVID-19 treatment which was previously deemed too risky for medical staff due to the potential for the spread of contagious disease from the patient’s breath. Professor Moshe Shoham is co-founder of Tamar Robotics, and the Technion is one of the company’s investors.
A New Strategy to Boost the Pace of Antiviral Drug Discovery
Novel Ideas Could Lead to Ways to Prevent and Treat Parkinson’s Disease
Unique Collaborations Are Driving Cancer-Related Innovation
Harnessing Personalized Medicine in Cancer Treatment